Miguel Pardo-Garcia - Publications

Lung cancer across borders: From molecular epidemiology to precision treatment strategies.

Journal: Therapeutic advances in medical oncology

Published: May 22, 2026

SEOM-AEEMT consensus on occupational cancer and cancer-associated disability.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 06, 2025

Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).

Journal: Therapeutic advances in medical oncology

Published: March 07, 2025

Nonbacterial Thrombotic Endocarditis (NBTE) Treated With Crizotinib in Lung Adenocarcinoma Harboring ROS-1 Rearrangement: Two Case Report and Review of Literature.

Journal: Clinical lung cancer

Published: October 20, 2024

Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN).

Journal: Clinical lung cancer

Published: October 05, 2024

Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 10, 2024

The sooner, the better: early clearance of plasma circulating tumor DNA in patients with advanced KRAS G12C mutant non-small cell lung cancer.

Journal: Translational lung cancer research

Published: December 18, 2023

Geographic differences in lung cancer: focus on carcinogens, genetic predisposition, and molecular epidemiology.

Journal: Therapeutic advances in medical oncology

Published: October 14, 2023

IPSOS trial: A "game changer" redefining first-line immunotherapy in platinum-ineligible NSCLC.

Journal: Med (New York, N.Y.)

Published: October 02, 2023

"Plasma-first" approach for molecular genotyping in non-small cell lung cancer: A narrative review.

Journal: The journal of liquid biopsy

Published: October 01, 2023

Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence.

Journal: Cancer treatment and research communications

Published: September 10, 2023

Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.

Journal: JAMA network open

Published: July 25, 2023